Showing results (431-440 of 519) with videos related to
Sort By:
Pageof 52
Gastroenterology|April 29, 2022
Prediction Models for Celiac Disease Development in Children From High-Risk Families: Data From the PreventCD CohortCaroline R Meijer, Renata Auricchio, Hein Putter, et al.European Journal of Cancer (Oxford, England : 1990)|March 30, 2023
Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trialRenu R Bahadoer, Geke A P Hospers, Corrie A M Marijnen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancerMichiel F G de Maat, Cornelis J H van de Velde, Naoyuki Umetani, et al.Cancer Gene Therapy|July 2, 2003
Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patientsAnand G Menon, Peter J K Kuppen, Sjoerd H van der Burg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrenceMichiel F G de Maat, Cornelis J H van de Velde, Martijn P J van der Werff, et al.Journal of Molecular and Cellular Cardiology|July 16, 2008
CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic eventsSaskia C A de Jager, Adriaan O Kraaijeveld, Robert W Grauss, et al.European Journal of Cancer (Oxford, England : 1990)|December 20, 2011
Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm dataRemi A Nout, Hein Putter, Ina M Jürgenliemk-Schulz, et al.Cancer Medicine|December 25, 2021
The added value of multi-state modelling in a randomized controlled trial: The HOVON 102 study re-analyzedKaterina Bakunina, Hein Putter, Jurjen Versluis, et al.Journal of the National Cancer Institute|September 20, 2017
Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05)Erik J Blok, Judith R Kroep, Elma Meershoek-Klein Kranenbarg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology studyJohn M S Bartlett, Kenneth J Bloom, Tammy Piper, et al.Pageof 52